Adiponectin and Insulin Resistance in Diabetic Nephropathy
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
Plasma adiponectin concentration is inversely associated with renal function. There is little
literature on adiponectin levels and regulation by antihypertensive medication with an
angiotensin II-receptor blocker (ARB), especially in subjects with type 2 diabetes in
different stage of chronic kidney disease (CKD).
Phase:
N/A
Details
Lead Sponsor:
Health Science Center of Xi'an Jiaotong University Health Science Center of Xi’an Jiaotong University
Collaborator:
Shanghai Jiao Tong University School of Medicine
Treatments:
Angiotensin II Angiotensin II Type 1 Receptor Blockers Losartan